Batm Advanced Communicat... Share Discussion Threads

[paulisi] 19/1/2021 09:05

Wrong - yesterday's spike was caused by Investor's chronicle share tip

[wheeze] 19/1/2021 07:45

Massive spike in volume yesterday suggests the RNS was leaked ?

[vago] 18/1/2021 18:39

I see a US$2bn company in the making, we will get a better idea where we are going and how long it will take with the next set of numbers, feb/march?

[rawdeal1] 18/1/2021 17:43

Could we be watching a "breakout" ... ?

[fse] 18/1/2021 17:40

I agree with ST synopsis. The scope of what BATM medical have to offer is really not being seen by Investors. I am very surprised and have been for some time that we do not have more BioTech people commenting on this thread.

BATM is becoming a much larger company altogether.

And thats to say nothing about Telco systems that are very much in the right place at the right time with the right products !

[nishg] 18/1/2021 15:51

One to watch, added further to my holdings.. DYOR

[sandy789] 18/1/2021 14:29

Thank you.

[rawdeal1] 18/1/2021 13:56

Brill .. ! Many thanks Paulisi

[paulisi] 18/1/2021 12:57

Target price 170pBATM Advanced Communications (BVC:100p), a provider of medical laboratory systems, diagnostic kits, cyber security and network solutions, has made three important announcements.Firstly, its COVID-19 tests have been proved effective in accurately detecting all variants of the virus, including the latest mutations. BATM's antigen test has 4+1 gene discovery capability, including the S-protein, compared with a market standard of one to three gene discovery. This enables it to provide more accurate results, reducing the risk of false positives and false negatives. It is being delivered to several private and government customers in Europe and other geographies.Secondly, associate company Ador Diagnostics has developed a new innovative technology that can provide sample-to-answer diagnostics of bacterial, viral or fungal infections using DNA or RNA sampling in 15-20 minutes compared with 60-90 minutes for polymerase chain reaction (PCR). Ador's NATlab molecular diagnostic bench-top analyser can analyse several pathogens (currently up to 400) at the same time, thus detecting all the possible pathogens associated with diseases such as meningitis, sepsis and respiratory diseases.By accurately detecting the right strain of a disease, the correct treatment can be started immediately – something that is not possible with PCR methods. Several universities and hospitals in the UK, Europe, Israel and the USA are co-operating with Ador and in-hospital trials will commence in the first half. Demand is likely to be strong given that the speed and accuracy of identifying an infection is vital in providing the correct treatment and containing potential disease outbreaks.Thirdly, BATM is selling its non-core NG Soft software subsidiary for US$33m (£24.5m) to unlock value for shareholders. The group will use the proceeds to accelerate growth in its core bio-medical, cyber security and network function virtualisation technology business, the latter is playing a critical role in the range of 5G services telecom operators can offer.The 444 per cent gain on BATM shares since I included them in my 2017 Bargain Shares portfolio has helped drive up the portfolio total return to 100 per cent. A 2020 cash profit multiple of 37 times to enterprise valuation is worth paying at this stage of its earnings upgrade cycle as this is a US$1bn (170p a share target) company in the making. Buy.

[sandy789] 18/1/2021 12:27

Does he give a fair value target price please?

[paulisi] 18/1/2021 12:17

Good old Simon Thompson at IC has tipped them againhttps://www.investorschronicle.co.uk/ideas/2021/01/18/technology-winners-for-the-new-normal/

[paulisi] 18/1/2021 12:12

Some big buying today - TASE dropped yesterday, so somewhat a surprise.

[wizzkid211] 16/1/2021 16:47

SANDY789
Good post!
You said "As the world shifts to 5G the future looks too attractive"
I would add that since HUAWEI are out of the game the future looks even better!
Good luck all.

[paulisi] 15/1/2021 19:33

That will also explain the additional investment in Ador, if they are manufacturing new test benches. They seem to be a bit behind on rolling out the covid/flu/cold test which was scheduled for Q3.

[paulisi] 15/1/2021 18:30

Thanks for the link - Zvi needs to make this common knowledge. Share price will jump when word gets out

[sandy789] 15/1/2021 17:34

The telecom arm and is definitely the more interesting arm of the business and i can't see it being sold unless one of the majors pays silly money. "IF" NVtime gains traction it may become an industry standard. As the world shifts to 5G the future looks too attractive to let someone else get the benefits of the work and investment Telco Systems have put in. Zvi is not likely to give anything away. What i find amusing is contributors who want Zvi fired when their investment goes down a few pence. He has built a substantial business out of the ashes of the 2000 crash and aint going anywhere.

[wizzkid211] 15/1/2021 17:30

Our ambitious task: To be able to give in the region of 100% accurate diagnostics for any human or animal pathogen - bacterial, fungal or viral - within minutes.

www.batm.com/rns-rnr/posts/2021/january/diagnostics-and-viral-evolution/?fbclid=IwAR1whB2eDFH7xE9u65CkG5-tk2zZv-IYLocZ244Ab1K_h7kJabhZbFG2eOA

[doccash] 15/1/2021 15:57

Hot and continued interest in covid needs continual re-examination so more talk The telecom side I think is the more profitable arm in the medium term

[paulisi] 15/1/2021 13:00

You do get the impression that Zvi's focus is on the medical side and that the technology side will be sold off.

[unctuous] 14/1/2021 19:50

Zvi also mentions a diagnostic suite for “long covid”. That has significant potential over the next couple of years.

[paulisi] 14/1/2021 08:13

Nice start again - will it continue?

[paulisi] 13/1/2021 22:13

Fair play - sounds like they have a rapid test for sepsis and meningitis close to launch.Very little mention of NFV, which could be a game changer in the Telco side of the business

[paulisi] 13/1/2021 17:48

Back to a pound...